Twist Bioscience Corp
TWST
Market Cap$3.13B
Close$
$42.26
19.8% downside
Current Fair Value
19.8% downsideOvervalued by 19.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.13 Billion |
|---|---|
| Enterprise Value | $2.94 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.6 |
| Beta | 1.78 |
| Outstanding Shares | 58,554,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -14.78 |
|---|---|
| PEG | 59 |
| Price to Sales | 10.54 |
| Price to Book Ratio | 6.59 |
| Enterprise Value to Revenue | 9.38 |
| Enterprise Value to EBIT | -17.22 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Twist Bioscience Corp
CEO: Emily Leproust Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary techno...